Page 6 - Nifty Pharma

Nifty Pharma index rallies nearly 3%; Lupin surges 10%, Cipla, Cadila up 3%

All the 10 constituents of the Nifty Pharma index were trading in the green.

Market Wrap, May 13: Here's All That Happened In The Markets Today

Sectorally, banking stocks rallied the most. The Nifty PSU Bank index jumped over 6 per cent to 1,238.05 while Nifty Bank climbed over 4 per cent to 19,635

Street signs: Banking stocks under pressure, FPI tally gets skewed and more

The performance of banking stocks is likely to weigh on the markets

Pharma stocks rally; Nifty Pharma index surges 10%, Ipca Labs hits new high

Torrent Pharmaceuticals also rose 15 per cent to a fresh 52-week high of Rs 2,380

Select pharma shares in focus, Nifty Pharma rebounds 16% from day's low

Aurobindo Pharma moved higher by 20 per cent to Rs 449, and witnessed 32 per cent rally in the intra-day deal.

Market Wrap, March 3: Sensex snaps 7-day losing streak, gains 480 pts

Sectorally, metal and pharma stocks gained the most. Nifty Metal index climbed 5.6 per cent to 2,321 levels while Nifty Pharma index ended at 7,921, up over 5 per cent

Pharma shares gain; Dr Reddy's, Alembic, Divis, Laurus Labs hit 52-wk highs

Wockhardt, Strides Pharma Science, Alembic Pharmaceuticals, Pfizer and IOL Chemicals & Pharmaceuticals were up in the range of 5 per cent to 9 per cent in intra-day trade today.

Glenmark and Lupin: Are pharma stocks a good contrarian bet?

Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.

Nifty Pharma index hits 5-year low; Glenmark at 7-year low post Q1 results

Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade

Tech view: Nifty Pharma is headed for a strong rally; watch for 9350 levels

In the last five sessions, the index has been hovering at 200-days moving average (DMA) located around 9230, as per daily chart. A major trigger for a bigger run stays at 9350 levels

Sector Watch: Nifty Pharma index slips up to 3% dragged by Sun Pharma

Nifty Pharma index emerged as the top sectoral loser on NSE in the morning deals on Monday, weighed down by the shares of Sun Pharmaceutical Industries, which slumped as much as 10 per cent.

Nifty Pharma index rises 2% as Sun Pharma, Lupin receive USFDA approval

Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the NSE after the drug maker announced USFDA approval of XELPROS to treat open-angle Glaucoma or Ocular Hypertension.

Nifty Pharma index hits 52-week high; Cipla, Sun Pharma touch 52-week highs

Nifty Pharma index hit a 52-week high of 10,142, rising 2%, in early morning deal, surpassing its previous high of 10,063 recorded on November 3, 2017 in intra-day trade on the NSE.

Nifty Pharma index set to post biggest weekly rally in 15 years

At 11:23 am; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.2% at 9,310, surging 8.2% thus far in current week.

Pharma stocks on a booster dose; Nifty Pharma up 12% in six days

Analysts attribute the run-up in pharma stocks to positive corporate announcements on the US drug regulatory front

Nifty Pharma index up for fifth straight day; Sun Pharma up 14% in a week

Marksans Pharma, Alembic Pharma, Caplin Point Lab, Ajanta Pharma, Bliss GVS Pharma, Granules India, Aurobindo Pharma and Wockhardt were up in the range of 10% to 30% in past one week.

Pharma shares in focus as Nifty Pharma index rises 2%

Sun Pharma, Cadila Healthcare, Dr Reddy's Laboratories, Cipla, Glenmark Pharma and Lupin from the Nifty Pharma index were up in the range of 2% to 3% on the NSE.

Nifty Pharma index hits 7-week high

Divi's Lab biggest gainer with over 50% rise in one month

Nifty Pharma index up 11% from May's low

At 12:05 pm; the Nifty Pharma index was up 1.3% at 9,703, surging 11% from 8,758 hit on May 29, 2017

Pharma shares under pressure; Nifty Pharma index down 3%

Lupin, Divis Lab, Aurobindo, Dishman Pharma, Jubilant Life, Natco Pharma and Pfizer were down 3%-7% on BSE.